B · Normal
[Binhui Biotechnology's Hong Kong stock listing has been filed with the China Securities Regulatory Commission] On September 4, the International Cooperation Department of the China Securities Regulatory Commission issued a notice on the overseas issuance and listing of Wuhan Binhui Biotechnology Co., Ltd. and the "full circulation" filing of domestic unlisted shares. The company plans to issue no more than 38,102,600 overseas listed ordinary shares and list them on the Hong Kong Stock Exchange. The company's 54 shareholders plan to convert a total of 150,933,379 domestic unlisted shares held into overseas listed shares and list them on the Hong Kong Stock Exchange.
Comments